Latest George Wilding Stories
MENLO PARK, Calif., March 30, 2011 /PRNewswire/ -- The best way to prevent the lethal spread of prostate cancer is by stopping cancer cell invasion of other tissues.
HOUSTON, Nov. 10, 2010 /PRNewswire/ -- Bellicum Pharmaceuticals, Inc., a company developing novel therapies that can be precisely controlled after delivery, today announced the appointment of four new members to its Clinical Advisory Board (CAB).
LOS ANGELES, Sept.
Pfizer announced today that it has named Mace L. Rothenberg, M.D. as Senior Vice President, Clinical Development and Medical Affairs for its Oncology Business Unit. Dr.
Metabolon, Inc., the leader in metabolomics-driven biomarker discovery and analysis, and the University of Michigan today announced an agreement on the commercial development of prostate cancer diagnostics.
SUNNYVALE, Calif., Sept. 11 /PRNewswire-FirstCall/ -- Pharmacyclics, Inc. (the "Company" or "Pharmacyclics") announced today that Christine A. White, M.D., Richard M. Levy Ph.D., Mr. Miles R. Gilburne and Richard A. Miller, M.D.
Advanced Cancer Therapeutics, LLC (ACT) announced today that industry veteran Gilles H. Tapolsky, Ph.D. has joined ACT as chief scientific officer. Dr. Tapolsky brings over 20 years of experience in corporate management, research and pharmaceutical development to ACT.
- Growing in low tufty patches.